FDA guidance
Diagnostic ECG Guidance (Including Non-Alarming ST Segment Measurement) - Guidance for…
FDA guidance · Final · issued Nov 4, 1998
Key facts
| Title | Diagnostic ECG Guidance (Including Non-Alarming ST Segment Measurement) - Guidance for Industry |
|---|---|
| Status | Final |
| Issue date | Nov 4, 1998 |
| Center | Center for Devices and Radiological Health |
| Issuing office | Center for Devices and Radiological Health |
| Communication type | Guidance Document |
| Regulated product | Medical Devices |
| Topics | Premarket |
| Docket number | FDA-2020-D-0957 |
| Open for comment | No |
| Document on fda.gov | fda.gov |
At a glance
- 1–9 Product codes referenced
- 1–9 Recognized standards referenced
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA guidance documents
FDA guidance documents describe the agency's current thinking on regulatory topics. Drafts are issued for comment before a final version is published.
Source: U.S. Food and Drug Administration (FDA), Guidance Documents